Coloplast A/S (OTCMKTS:CLPBY) Hits New 12-Month Low – Time to Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $5.83 and last traded at $5.8350, with a volume of 1228 shares trading hands. The stock had previously closed at $5.92.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CLPBY. Kepler Capital Markets raised shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. The Goldman Sachs Group downgraded Coloplast A/S from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Coloplast A/S presently has an average rating of “Hold”.

Coloplast A/S Stock Down 1.5%

The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50. The company has a market cap of $13.14 billion, a price-to-earnings ratio of 41.64, a price-to-earnings-growth ratio of 1.87 and a beta of 0.18. The firm’s 50 day simple moving average is $6.34 and its 200 day simple moving average is $7.44.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%.The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. Sell-side analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.